|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA and EMA (2012)) |
IUPAC Name ![]() |
| [(8R)-1-[3-(phenoxy)propyl]-1-azoniabicyclo[2.2.2]octan-8-yl] 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8544 | aclidinium bromide |
Synonyms ![]() |
| LAS W-330 |
| LAS-34273 |
| Tudorza Pressair® |
Database Links ![]() |
|
| CAS Registry No. | 727649-81-2 |
| ChEBI | CHEBI:65346 |
| ChEMBL Ligand | CHEMBL1194325 |
| DrugBank Ligand | DB08897 |
| PubChem CID | 11434515 |
| Search Google for chemical match using the InChIKey | ASMXXROZKSBQIH-VITNCHFBSA-N |
| Search Google for chemicals with the same backbone | ASMXXROZKSBQIH |
| Search PubMed clinical trials | aclidinium bromide |
| Search PubMed titles | aclidinium bromide |
| Search PubMed titles/abstracts | aclidinium bromide |
| Wikipedia | Aclidinium bromide |
| Comments |
| Note that the approved drug is the bromide salt (PubChem CID 11434515). |